JANUS HENDERSON GROUP PLC OWNS 10.5% OF LIGAND

Company

LIGAND PHARMACEUTICALS INC

Filed

January 10, 2020

Accession Number

0001274173-20-000002

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →